|
Volumn 1, Issue 2, 2004, Pages 111-125
|
Pharmacogenetics of lipid diseases.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
APOLIPOPROTEIN E;
CHOLESTEROL;
LIPID;
ANIMAL;
ARTERIOSCLEROSIS;
BIOLOGICAL MODEL;
CARDIOVASCULAR DISEASE;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
GENETICS;
HUMAN;
HYPERLIPIDEMIA;
METABOLISM;
PHARMACOGENETICS;
REVIEW;
ANIMALS;
ANTILIPEMIC AGENTS;
APOLIPOPROTEINS E;
ARTERIOSCLEROSIS;
CARDIOVASCULAR DISEASES;
CHOLESTEROL;
HUMANS;
HYPERLIPIDEMIAS;
LIPIDS;
MODELS, BIOLOGICAL;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
VARIATION (GENETICS);
MLCS;
MLOWN;
|
EID: 16544370435
PISSN: 14739542
EISSN: None
Source Type: Journal
DOI: 10.1186/1479-7364-1-2-111 Document Type: Review |
Times cited : (11)
|
References (103)
|